Table 1.
Characteristics | No. of patients (%) | Mean ± SD | P value |
---|---|---|---|
Gender | |||
Male | 38 (31.7) | 0.4753 ± 0.8222 | .834 |
Female | 82 (68.3) | 0.5029 ± 0.5899 | |
Age(years) | |||
<45 | 59 (49.2) | 0.4302 ± 0.5834 | .305 |
≥45 | 61 (50.8) | 0.5560 ± 0.7416 | |
Extrathyroidal extension | |||
Yes | 39 (32.5) | 0.2288 ± 0.2322 | <.001a |
No | 81 (67.5) | 0.6219 ± 0.7673 | |
T stage | |||
T1‐2 | 80 (66.7) | 0.6278 ± 0.7703 | <.001a |
T3‐4 | 40 (33.3) | 0.2268 ± 0.2295 | |
Lymph node metastasis | |||
Yes | 84 (70.0) | 0.3898 ± 0.5779 | .022a |
No | 36 (30.0) | 0.7376 ± 0.8008 | |
TNM stage | |||
I‐II | 79 (65.8) | 0.5380 ± 0.6441 | .321 |
III‐IV | 41 (34.2) | 0.4096 ± 0.7143 | |
Multifocality | |||
Yes | 64 (53.3) | 0.4983 ± 0.7215 | .943 |
No | 56 (46.7) | 0.4894 ± 0.6092 | |
Microcarcinoma | |||
Yes | 35 (29.2) | 0.8046 ± 0.9174 | .011a |
No | 85 (70.8) | 0.3663 ± 0.4859 | |
Tumor size (cm) | |||
≤2 | 77 (64.2) | 0.6448 ± 0.7760 | <.001a |
>2 | 43 (35.8) | 0.2245 ± 0.2478 |
Significant association.